Literature DB >> 10699137

Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen.

L L Barton1, N J Hyndman.   

Abstract

Lymphocytic choriomeningitis virus (LCMV), a human zoonosis caused by a rodent-borne arenavirus, has been associated with both postnatal and intrauterine human disease. Infection in man is acquired after inhalation, ingestion, or direct contact with virus found in the urine, feces, and saliva of infected mice, hamsters, and guinea pigs. Congenital LCMV infection is a significant, often unrecognized cause of chorioretinitis, hydrocephalus, microcephaly or macrocephaly, and mental retardation. Acquired LCMV infection, asymptomatic in approximately one third of individuals, is productive of central nervous system manifestations in one half of the remaining cases. Aseptic meningitis or meningoencephalitis are the predominant syndromes, although transverse myelitis, a Guillain-Barré-type syndrome, as well as transient and permanent acquired hydrocephalus have also been reported. Fatalities are rare. We report a patient with meningoencephalitis attributable to LCMV and discuss the spectrum of central nervous system disease, newer diagnostic modalities, and preventive strategies. lymphocytic choriomeningitis virus, aseptic meningitis, meningoencephalitis, zoonosis, hydrocephalus, arenavirus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699137     DOI: 10.1542/peds.105.3.e35

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

Review 1.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Hantavirus and arenavirus antibody prevalence in rodents and humans in Trentino, Northern Italy.

Authors:  H Kallio-Kokko; J Laakkonen; A Rizzoli; V Tagliapietra; I Cattadori; S E Perkins; P J Hudson; A Cristofolini; W Versini; O Vapalahti; A Vaheri; H Henttonen
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Authors:  Juan C Zapata; Marco Goicochea; Yuka Nadai; Lindsay M Eyzaguirre; Jean K Carr; Luke J Tallon; Lisa Sadzewicz; Garry Myers; Claire M Fraser; Qi Su; Mahmoud Djavani; Igor S Lukashevich; Maria S Salvato
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 4.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

5.  Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage.

Authors:  Maya F Kotturi; Jason Botten; Matt Maybeno; John Sidney; Jean Glenn; Huynh-Hoa Bui; Carla Oseroff; Shane Crotty; Bjoern Peters; Howard Grey; Daniel M Altmann; Michael J Buchmeier; Alessandro Sette
Journal:  Immunome Res       Date:  2010-05-17

Review 6.  Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult.

Authors:  Daniel J Bonthius
Journal:  Semin Pediatr Neurol       Date:  2012-09       Impact factor: 1.636

7.  Mouse-to-human transmission of variant lymphocytic choriomeningitis virus.

Authors:  Sébastien Emonet; Karine Retornaz; Jean-Paul Gonzalez; Xavier de Lamballerie; Rémi N Charrel
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

8.  Spatial and temporal dynamics of lymphocytic choriomeningitis virus in wild rodents, northern Italy.

Authors:  Valentina Tagliapietra; Roberto Rosà; Heidi C Hauffe; Juha Laakkonen; Liina Voutilainen; Olli Vapalahti; Antti Vaheri; Heikki Henttonen; Annapaola Rizzoli
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

9.  A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.

Authors:  Maya F Kotturi; Jason Botten; John Sidney; Huynh-Hoa Bui; Lori Giancola; Matt Maybeno; Josie Babin; Carla Oseroff; Valerie Pasquetto; Jason A Greenbaum; Bjoern Peters; Joey Ting; Danh Do; Lo Vang; Jeff Alexander; Howard Grey; Michael J Buchmeier; Alessandro Sette
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

10.  Independent lineage of lymphocytic choriomeningitis virus in wood mice (Apodemus sylvaticus), Spain.

Authors:  Juan Ledesma; Cesare Giovanni Fedele; Francisco Carro; Lourdes Lledó; María Paz Sánchez-Seco; Antonio Tenorio; Ramón Casimiro Soriguer; José Vicente Saz; Gerardo Domínguez; María Flora Rosas; Jesús Félix Barandika; María Isabel Gegúndez
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.